508 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
GSK GlaxoSmithKline PLC $39.21 $97.25B Downtrend
Article Searches
Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site http://www.zacks.com/stock/news/415702/thermo-fisher-acquires-glaxosmithklines-drug-production-site?cid=CS-ZC-FT-415702 May 17, 2019 - The latest acquisition aligns with Thermo Fisher's (TMO) strategy of enhancing capabilities of its Pharma Services through the right balance of capital investment, and merger and acquisition.
What's in Store for Axsome (AXSM) This Earnings Season? http://www.zacks.com/stock/news/410492/whats-in-store-for-axsome-axsm-this-earnings-season?cid=CS-ZC-FT-410492 May 07, 2019 - On Axsome's (AXSM) first-quarter earnings call, investors will look for its progress with the CNS pipeline candidates and the regulatory updates on the same.
The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo http://www.zacks.com/stock/news/409269/the-zacks-analyst-blog-highlights-merck-pfizer-abbvie-sanofi-and-glaxo?cid=CS-ZC-FT-409269 May 06, 2019 - The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo
Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod http://www.zacks.com/stock/news/408311/pharma-stock-roundup-mrk-lly-pfe-report-q1-earnings-sny-abbv-drugs-get-eu-nod?cid=CS-ZC-FT-408311 May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
GlaxoSmithKline plc (GSK) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/01/glaxosmithkline-plc-gsk-q1-2019-earnings-call-tran.aspx?source=iedfolrf0000001 May 01, 2019 - GSK earnings call for the period ending March 31, 2019.
GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4258612-glaxosmithkline-plc-gsk-ceo-emma-walmsley-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 01, 2019 - GlaxoSmithKline plc (NYSE:GSK) Q1 2019 Earnings Conference Call May 01, 2019 09:00 AM ET Company Participants Sarah Elton-Farr - Head, Investor Relations Emma Walmsley - Chief Executive Officer Iain M
Can Allergan (AGN) Beat Earnings Estimates Again in Q1? http://www.zacks.com/stock/news/406700/can-allergan-agn-beat-earnings-estimates-again-in-q1?cid=CS-ZC-FT-406700 May 01, 2019 - Allergan's (AGN) key products like Botox are likely to provide top-line support in Q1 as loss of exclusivity of several products hurts sales
What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? http://www.zacks.com/stock/news/405507/whats-in-store-for-ani-pharmaceuticals-anip-q1-earnings?cid=CS-ZC-FT-405507 Apr 30, 2019 - ANI Pharmaceuticals (ANIP) will provide updates on product launches, when it releases first-quarter 2019 results.
What's in Store for BioSpecifics (BSTC) This Earnings Season? http://www.zacks.com/stock/news/405553/whats-in-store-for-biospecifics-bstc-this-earnings-season?cid=CS-ZC-FT-405553 Apr 30, 2019 - BioSpecifics Technologies (BSTC) will provide updates on Xiaflex and pipeline progress, when it releases first-quarter 2019 results.
Teva (TEVA) to Report Q1 Earnings: What's in the Cards? http://www.zacks.com/stock/news/405122/teva-teva-to-report-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-405122 Apr 29, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to hurt Teva's (TEVA) sales in Q1.

Pages: 123456...51

Page 1>